Melynda Tracee Spring, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12927 Moreno Beach Dr, Apt. 5201, Moreno Valley, CA 92555 Phone: 951-485-5172 |
Shu-ning Yu Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 |
Troy Gasner Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 26440 Field St, Moreno Valley, CA 92555 Phone: 951-442-6347 |
Mrs. Bonnie Springer, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23651 Sunnymead Blvd, Moreno Valley, CA 92553 Phone: 951-485-2255 |
Dr. Jonathan Dara Heng, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23180 Hemlock Ave Ste 100, Moreno Valley, CA 92557 Phone: 951-266-9880 Fax: 951-289-7964 |
Therapy Buddy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23180 Hemlock Ave Ste 100, Moreno Valley, CA 92557 Phone: 951-266-9880 |
News Archive
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will be presenting new data at Neuroscience 2013, 9-13 November, San Diego (USA).
The same kinds of impulsive behavior that lead some people to abuse alcohol and other drugs may also be an important contributor to an unhealthy relationship with food, according to new research from the University of Georgia.
Using biological markers-genetic characteristics that are associated with some patients with breast cancer-can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
› Verified 5 days ago